United States Biopsy Devices Market Outlook to 2023

  • ID: 4142850
  • Report
  • Region: United States
  • 131 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Becton Dickinson and Co
  • C. R. Bard Inc
  • Cook Group Inc
  • MORE
United States Biopsy Devices Market Outlook to 2023

Summary:

The new report, "United States Biopsy Devices Market Outlook to 2023", provides key market data on the United States Biopsy Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Biopsy Guns & Needles, Biopsy Core Needles & Devices, Biopsy Fine Aspiration Needles & Devices, Biopsy Disposable Vacuum-Assisted Needle Devices, Biopsy Forceps and Biopsy Punches.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope:

- Market size and company share data for Biopsy Devices market segments - Biopsy Guns & Needles, Biopsy Core Needles & Devices, Biopsy Fine Aspiration Needles & Devices, Biopsy Disposable Vacuum-Assisted Needle Devices, Biopsy Forceps and Biopsy Punches.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the United States Biopsy Devices market.
- Key players covered include C. R. Bard Inc, Becton Dickinson and Co, Cook Group Inc and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Becton Dickinson and Co
  • C. R. Bard Inc
  • Cook Group Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Biopsy Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Biopsy Devices Market, United States
3.1 Biopsy Devices Market, United States, Revenue ($m), 2009-2016
3.2 Biopsy Devices Market, United States, Revenue ($m), 2016-2023
3.2.1 Biopsy Core Needles & Devices Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.2 Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.3 Biopsy Forceps Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.4 Biopsy Guns & Needles Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.5 Biopsy Punches Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.6 Biopsy Core Needles & Devices Market, United States, Revenue ($m), by Segment, 2016-2023
3.2.7 Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), by Segment, 2016-2023
3.2.8 Biopsy Forceps Market, United States, Revenue ($m), by Segment, 2016-2023
3.2.9 Biopsy Guns & Needles Market, United States, Revenue ($m), by Segment, 2016-2023
3.2.10 Biopsy Punches Market, United States, Revenue ($m), by Segment, 2016-2023
3.3 Biopsy Devices Market, United States, Volume (Units), 2009-2016
3.4 Biopsy Devices Market, United States, Volume (Units), 2016-2023
3.4.1 Biopsy Core Needles & Devices Market, United States, Volume (Units), by Segment, 2009-2016
3.4.2 Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), by Segment, 2009-2016
3.4.3 Biopsy Forceps Market, United States, Volume (Units), by Segment, 2009-2016
3.4.4 Biopsy Guns & Needles Market, United States, Volume (Units), by Segment, 2009-2016
3.4.5 Biopsy Punches Market, United States, Volume (Units), by Segment, 2009-2016
3.4.6 Biopsy Core Needles & Devices Market, United States, Volume (Units), by Segment, 2016-2023
3.4.7 Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), by Segment, 2016-2023
3.4.8 Biopsy Forceps Market, United States, Volume (Units), by Segment, 2016-2023
3.4.9 Biopsy Guns & Needles Market, United States, Volume (Units), by Segment, 2016-2023
3.4.10 Biopsy Punches Market, United States, Volume (Units), by Segment, 2016-2023
3.5 Biopsy Devices Market, United States, Average Price ($), 2009-2023
3.6 Biopsy Devices Market, United States, Distribution Share by Revenue ($m), 2015-2016
3.7 Biopsy Devices Market, United States, Company Share by Revenue ($m), 2016
4 Overview of Key Companies in United States, Biopsy Devices Market
4.1 C. R. Bard Inc
4.1.1 Company Overview
4.2 Becton Dickinson and Co
4.2.1 Company Overview
4.3 Cook Group Inc
4.3.1 Company Overview
4.4 Argon Medical Devices Inc.
4.4.1 Company Overview
4.5 Devicor Medical Products Inc
4.5.1 Company Overview
5 Biopsy Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Teleflex Acquires Vascular Solutions for up to USD1 Billion
6.1.2 Boston Scientific Acquires EndoChoice for USD210 Million in Tender Offer
6.1.3 Avant Diagnostics Acquires Theranostics Health
6.2 Debt Offerings
6.2.1 C. R. Bard Prices Public Offering of 3% Notes Due 2026 for USD500 Million
6.3 Partnerships
6.3.1 Exosome Diagnostics Enters into Agreement with Amgen
6.3.2 Devicor Medical Products Enters into Distribution Agreement with Endomagnetics
6.3.3 Scion Medical Technologies Enters into Distribution Agreement with Mermaid Medical
6.3.4 Fluxion Bioscience Forms Partnership with University of Texas Health Science Center
6.4 Venture Financing
6.4.1 VIDA Diagnostics Raises USD5.1 Million in Series B Round of Financing
6.4.2 Veran Medical Technologies Raises USD31 Million in Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jan 30, 2017: Dr. Yaron Pereg Appointed as New Chief Development Officer
7.1.2 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team
7.1.3 Jan 03, 2017: Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer
7.1.4 Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors
7.1.5 Oct 26, 2016: Elisha W. Finney Announces Plan to Retire as CFO of Varian Medical Systems
7.1.6 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
7.1.7 Sep 26, 2016: Jon Giacomin of Cardinal Health Elected Chairman of HDA Board of Directors
7.1.8 Sep 08, 2016: iCAD Announces Management Transition
7.1.9 Aug 22, 2016: Judy Bruner Appointed to Board of Directors of Varian Medical Systems; Venkatraman Thyagarajan Retires from Varian Board
7.1.10 Jul 26, 2016: Merit Medical Announces Appointment of New Director
7.1.11 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
7.1.12 Jun 30, 2016: Cardinal Health Appoints Pamela O. Kimmet Chief Human Resources Officer
7.1.13 Mar 07, 2016: Varian Medical Systems Announces Particle Therapy Scientific Advisory Board
7.1.14 Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors
7.2 Financial Announcements
7.2.1 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016
7.2.2 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017
7.2.3 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
7.2.4 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017
7.2.5 Jan 26, 2017: Bard Announces Fourth Quarter Results
7.2.6 Jan 25, 2017: Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2017
7.2.7 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook
7.2.8 Jan 10, 2017: Stryker provides 2016 preliminary net sales results
7.2.9 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016
7.2.10 Nov 02, 2016: iCAD Reports Third Quarter 2016 Financial Results
7.2.11 Oct 31, 2016: Cardinal Health Reports First-quarter Results for Fiscal Year 2017
7.2.12 Oct 27, 2016: Stryker reports third quarter 2016 results
7.2.13 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
7.2.14 Oct 26, 2016: Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2016
7.2.15 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016
7.2.16 Oct 25, 2016: Bard Announces Third Quarter Results
7.2.17 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results
7.2.18 Aug 03, 2016: EndoChoice Announces Second Quarter 2016 Financial Results
7.2.19 Aug 02, 2016: Cardinal Health Reports Q4 And Fiscal 2016 Results, Provides Fiscal 2017 Outlook
7.2.20 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
7.2.21 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
7.2.22 Jul 27, 2016: iCAD Reports Second Quarter 2016 Financial Results
7.2.23 Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016
7.2.24 Jul 27, 2016: Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2016
7.2.25 Jul 26, 2016: Bard Announces Second Quarter Results
7.2.26 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results
7.2.27 Jul 21, 2016: Stryker reports second quarter 2016 results
7.2.28 Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016
7.2.29 Apr 27, 2016: Varian Medical Systems Reports Results For Second Quarter Of Fiscal Year 2016
7.2.30 Apr 27, 2016: Bard Announces First Quarter Results
7.3 Legal And Regulatory
7.3.1 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia
7.3.2 Dec 23, 2016: Cardinal Health Announces Civil Settlement with DOJ
7.4 Other Significant Developments
7.4.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
7.4.2 Jul 21, 2016: Varian Medical Systems Announces Company Name For Imaging Components Business
7.4.3 Jul 19, 2016: Braeburn Pharmaceuticals to Conduct First Series of Probuphine (buprenorphine) Implant Trainings on July 22, 23 and 24 for Qualified Healthcare Providers in US
7.4.4 Jun 28, 2016: Allied Minds Strengthens Commercialization Partnership with The MITRE
7.4.5 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation
7.4.6 May 19, 2016: Largest Hospital Chain in India Selects Varian Advanced Radiotherapy Equipment
7.5 Strategy And Business Planning
7.5.1 Mar 03, 2016: Varian Medical Systems Breaks Ground On New Brazil Facility
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
5.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact Us
8.4 Disclaimer

1.1 List of Tables
Table 1: Biopsy Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 2: Biopsy Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 3: Biopsy Core Needles & Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 4: Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 6: Biopsy Guns & Needles Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 7: Biopsy Punches Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 8: Biopsy Core Needles & Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 9: Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 10: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 11: Biopsy Guns & Needles Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 12: Biopsy Punches Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 13: Biopsy Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 14: Biopsy Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 15: Biopsy Core Needles & Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 16: Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 17: Biopsy Forceps Market, United States, Volume (Units), Historic, 2009-2016
Table 18: Biopsy Guns & Needles Market, United States, Volume (Units), Historic, 2009-2016
Table 19: Biopsy Punches Market, United States, Volume (Units), Historic, 2009-2016
Table 20: Biopsy Core Needles & Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 21: Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 22: Biopsy Forceps Market, United States, Volume (Units), Forecast, 2016-2023
Table 23: Biopsy Guns & Needles Market, United States, Volume (Units), Forecast, 2016-2023
Table 24: Biopsy Punches Market, United States, Volume (Units), Forecast, 2016-2023
Table 25: Biopsy Devices Market, United States, Average Price ($) Historic, 2009-2023
Table 26: Biopsy Devices Market, United States, Average Price ($), Forecast, 2016-2023
Table 27: Biopsy Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 28: Biopsy Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 29: Biopsy Devices Market Pipeline Products
Table 30: Teleflex Acquires Vascular Solutions for up to USD1 Billion
Table 31: Boston Scientific Acquires EndoChoice for USD210 Million in Tender Offer
Table 32: Avant Diagnostics Acquires Theranostics Health
Table 33: C. R. Bard Prices Public Offering of 3% Notes Due 2026 for USD500 Million
Table 34: Exosome Diagnostics Enters into Agreement with Amgen
Table 35: Devicor Medical Products Enters into Distribution Agreement with Endomagnetics
Table 36: Scion Medical Technologies Enters into Distribution Agreement with Mermaid Medical
Table 37: Fluxion Bioscience Forms Partnership with University of Texas Health Science Center
Table 38: VIDA Diagnostics Raises USD5.1 Million in Series B Round of Financing
Table 39: Veran Medical Technologies Raises USD31 Million in Venture Financing
Table 40: Total Number of Primary Research Participants, General Surgery Market, by Country

1.2 List of Figures
Figure 1: Biopsy Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 2: Biopsy Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 3: Biopsy Core Needles & Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 4: Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 5: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Biopsy Guns & Needles Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 7: Biopsy Punches Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 8: Biopsy Core Needles & Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 9: Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 10: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 11: Biopsy Guns & Needles Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 12: Biopsy Punches Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 13: Biopsy Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 14: Biopsy Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 15: Biopsy Core Needles & Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 16: Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 17: Biopsy Forceps Market, United States, Volume (Units), Historic, 2009-2016
Figure 18: Biopsy Guns & Needles Market, United States, Volume (Units), Historic, 2009-2016
Figure 19: Biopsy Punches Market, United States, Volume (Units), Historic, 2009-2016
Figure 20: Biopsy Core Needles & Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 21: Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 22: Biopsy Forceps Market, United States, Volume (Units), Forecast, 2016-2023
Figure 23: Biopsy Guns & Needles Market, United States, Volume (Units), Forecast, 2016-2023
Figure 24: Biopsy Punches Market, United States, Volume (Units), Forecast, 2016-2023
Figure 25: Biopsy Devices Market, United States, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • C. R. Bard Inc
  • Becton Dickinson and Co
  • Cook Group Inc
  • Argon Medical Devices Inc.
  • Devicor Medical Products Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll